SCHEMBL18230436

SCHEMBL18230436

O=C(Nc1nc(-c2ncccn2)cs1)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ GRM1 Q13255 1/20 0.61
▸ ADORA3 P0DMS8 6/20 0.61
▸ KDM4A O75164 1/20 0.61
▸ KDM4B O94953 1/20 0.61
▸ KDM5B Q9UGL1 1/20 0.61
▸ MPL P40238 5/20 0.60
▸ PARP1 P09874 1/20 0.56
▸ KDM4E B2RXH2 1/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ SCD O00767 1/20 0.53
▸ GSTO1 P78417 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18230323 0.89 ADORA3 (0.79) GRM1ADORA3KDM4AKDM4BKDM5B
SCHEMBL31265595 0.85 PARP1 (0.74) ADORA3MPLPARP1MEN1MAPT
SCHEMBL26884069 0.81 GSTO1 (0.62) GRM1ADORA3KDM4AKDM4BKDM5B
SCHEMBL18236300 0.80 GRM1 (0.53) GRM1ADORA3KDM4AKDM4BKDM5B
SCHEMBL21376543 0.79 ADORA3 (0.60) GRM1ADORA3KDM4AKDM4BKDM5B
SCHEMBL17107141 0.78 SCD (0.64) ADORA3KDM4AKDM4BKDM5BPARP1
SCHEMBL21376789 0.77 GRM1 (0.63) GRM1ADORA3KDM4AKDM4BKDM5B
SCHEMBL663231 0.76 KDM4A (0.64) GRM1ADORA3KDM4AKDM4BKDM5B
SCHEMBL29379460 0.76 KDM4A (0.64) GRM1ADORA3KDM4AKDM4BKDM5B
SCHEMBL18997292 0.76 GRM1 (1.00) GRM1ADORA3KDM4AKDM4BKDM5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016183173-A1 ANTIPARASITIC COMPOUNDS Avista Pharma Solutions (US) 2016-11-17 — — WO disclosed
WO-2016183173-A1 ANTIPARASITIC COMPOUNDS Avista Pharma Solutions (US) 2016-11-17 — — WO disclosed
Send feedback